Visx raises $59 million:
This article was originally published in Clinica
Visx has raised almost $59 million through its public offering of 2.5 million shares at $23.75 per share. The ophthalmic laser developer will use the proceeds mainly for R&D. Its excimer laser system for photorefractive keratectomy was recommended for approval by an FDA advisory panel last month (see Clinica No 678, p 20).